A Risk-Benefit Evaluation of Aciclovir for the Treatment and Prophylaxis of Herpes Simplex Virus Infections
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 23 (2) , 131-142
- https://doi.org/10.2165/00002018-200023020-00004
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Oral acyclovir in prevention of herpes labialis: A randomized, double-blind, multi-centered clinical trialOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1998
- Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.Journal of Clinical Investigation, 1997
- The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.Sexually Transmitted Infections, 1993
- Herpes simplex virus infections during the decade since the licensure of acyclovirJournal of Medical Virology, 1993
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- Suppression of Frequently Recurring Genital HerpesNew England Journal of Medicine, 1984
- Treatment of First Episodes of Genital Herpes Simplex Virus Infection with Oral AcyclovirNew England Journal of Medicine, 1983
- Topical acyclovir in the treatment of initial genital herpes.Sexually Transmitted Infections, 1983
- A Trial of Topical Acyclovir in Genital Herpes Simplex Virus InfectionsNew England Journal of Medicine, 1982
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981